Non-nucleoside reverse transcriptase inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 471/04 (2006.01) A61K 31/4162 (2006.01) A61K 31/4353 (2006.01) A61P 31/18 (2006.01) C07D 487/04 (2006.01)

Patent

CA 2683046

Compounds of formula (I), wherein R1, R2, R3, R4, Ra, X, X1, and Y are as defined herein or pharmaceutically acceptable salts thereof, inhibit HIV-1 reverse transcriptase and afford a method for prevention and treatment of HIV-1 infections and the treatment of AIDS and/or ARC. The present invention also relates to compositions containing compounds of formula (I) useful for the prevention and treatment of HIV-1 infections and the treatment of AIDS and/or ARC.

L'invention concerne des composés de formule (I), dans laquelle R1, R2, R3, R4, Ra, X, X1 et Y sont tels que définis dans le descriptif, ou des sels pharmaceutiquement acceptables desdits composés. Lesdits composés, qui inhibent la transcriptase inverse du VIH-1, constituent un moyen de prévention et de traitement des infections dues au VIH-1, et de traitement du SIDA et/ou du syndrome associé au SIDA (SAS). La présente invention concerne également des compositions contenant des composés de formule (I) utiles pour prévenir et traiter les infections par le VIH-1 et traiter le SIDA et/ou le SAS.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Non-nucleoside reverse transcriptase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Non-nucleoside reverse transcriptase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-nucleoside reverse transcriptase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1776806

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.